Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:06:43 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Q:RPRX - ROYALTY PHARMA PLC - http://www.reprosrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RPRX - Q0.228.59·28.600.528.62+0.210.7503.514,2412,43228.41  28.73  28.3935.70  25.9210:47:59Apr 1915 min RT 2¢

Recent Trades - Last 10 of 2432
Time ETExPriceChangeVolume
10:48:05Q28.600.197
10:48:05Q28.600.191,993
10:48:05Q28.600.19200
10:48:05Q28.600.1917
10:48:05Q28.600.19193
10:48:05Q28.600.19107
10:48:05Q28.600.19100
10:48:05Q28.600.192
10:48:05Q28.600.198
10:48:05Q28.60050.190559

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-19 08:15U:RPRXNews ReleaseRoyalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
2024-04-17 08:15U:RPRXNews ReleaseRoyalty Pharma Declares Second Quarter 2024 Dividend
2024-02-28 16:15U:RPRXNews ReleaseRoyalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference
2024-02-15 07:30U:RPRXNews ReleaseRoyalty Pharma Reports Q4 and Full Year 2023 Results
2024-01-30 16:15U:RPRXNews ReleaseRoyalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
2024-01-19 08:15U:RPRXNews ReleaseRoyalty Pharma Announces Dividend Increase
2024-01-08 07:00U:RPRXNews ReleaseRoyalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
2023-11-27 16:15U:RPRXNews ReleaseRoyalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
2023-11-13 08:10U:RPRXNews ReleaseRoyalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
2023-11-13 08:00U:RPRXNews ReleaseTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
2023-11-08 07:00U:RPRXNews ReleaseRoyalty Pharma Reports Third Quarter 2023 Results
2023-10-19 07:59U:RPRXNews ReleaseRoyalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics ¢ € ™ Royalty on Evrysdi
2023-10-16 16:15U:RPRXNews ReleaseRoyalty Pharma Declares Fourth Quarter 2023 Dividend
2023-10-11 16:15U:RPRXNews ReleaseRoyalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
2023-09-21 08:25U:RPRXNews ReleaseRoyalty Pharma Appoints Eric Schneider as Chief Technology Officer
2023-09-05 16:15U:RPRXNews ReleaseRoyalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
2023-09-05 16:01U:RPRXNews ReleaseAscendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
2023-09-05 08:25U:RPRXNews ReleaseRoyalty Pharma to Present at Upcoming Investor Conferences
2023-08-24 06:30U:RPRXNews ReleaseRoyalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin ‚ ® (Nadofaragene Firadenovec-Vncg)